We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ESLOF market cap is 97.03B. The company's latest EPS is EUR 5.0437 and P/E is 42.98.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 17.39B | 14.43B | 19.82B | 24.49B | 25.4B |
| Operating Income | 1.65B | 459M | 2.31B | 3.16B | 3.18B |
| Net Income | 1.08B | 85M | 1.45B | 2.15B | 2.29B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 52.58B | 52.32B | 59.42B | 60.56B | 60.52B |
| Total Liabilities | 17.25B | 19.52B | 23.54B | 22.41B | 21.63B |
| Total Equity | 35.33B | 32.8B | 35.88B | 38.15B | 38.89B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 3.3B | 2.95B | 4.55B | 4.78B | 4.86B |
| Investing | -1.69B | -480M | -8.06B | -2.62B | -1.72B |
| Financing | 1.38B | 1.5B | -2.04B | -3.58B | -2.43B |
| Market Cap | 97.03B |
| Price to Earnings Ratio | 42.98 |
| Price to Sales Ratio | 3.87 |
| Price to Cash Ratio | 38.46 |
| Price to Book Ratio | 2.53 |
| Dividend Yield | - |
| Shares Outstanding | 453.83M |
| Average Volume (1 week) | 444 |
| Average Volume (1 Month) | 1.5k |
| 52 Week Change | 6.98% |
| 52 Week High | 234.37 |
| 52 Week Low | 166.75 |
| Spread (Intraday) | 6.45 (2.93%) |
| Company Name | Essilor Luxottica (PK) |
| Address |
147 rue de paris charenton-le-pont, val-de-marne 94220 |
| Website | https://www.essilorluxottica.com |
| Industry | ophthalmic goods (3851) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
